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Abstract
Background: Increasing numbers of infants are receiving prescription medications for symptoms associated with
gastroesophageal reflux. Our aim was to prospectively measure reported gastroesophageal reflux symptoms in
healthy term infants for the first six months of life.
Methods: In a prospective cohort study in the rural Upper Peninsula of Michigan, 128 consecutive maternal-infant
pairs were followed for six months and administered the Infant Gastroesophageal Reflux Questionnaire Revised (I-
GERQ-R) at the one-month, two-month, four-month, and six-month well-child visits.
Results: The I-GERQ-R scores decreased with age. Average scores were 11.74 (SE = 5.97) at one-month, 9.97(4.92)
at two-months, 8.44(4.39) at four-months, and 6.97(4.05) at six months. Symptoms associated with colic were
greatest at one month of age.
Conclusion: Symptoms of gastroesophageal reflux as measured by the I-GERQ-R decrease with age in the first six
months of life in otherwise healthy infants; however the I-GERQ-R may have difficulty differentiating
gastroesophageal reflux disease from colic in those under 3 months of age.
Background
Gastroesophageal reflux (GER) can be a normal physio-
logical process that occurs in healthy infants, children,
and adults. GER occurs when gastric contents move
into the esophagus as the result of transient relaxations
of the lower esophageal sphincter (LES), an abrupt
decrease in LES pressure to the level of intragastric
pressure unrelated to swallowing, or when the LES tone
does not compensate for changes in abdominal pressure
[1]. The definition of gastroesophageal reflux disease
(GERD), especially in infants, is nebulous. Recently, an
expert panel opined that GERD occurred when the
reflux of gastric contents is the cause of “troublesome
symptoms” and/or complications. “Troublesome” was
defined as having “an adverse effect on the well-being”
of the patient. The panel did not endorse any objective
measures for diagnosing GERD[2].
Another expert panel concluded that there was no evi-
dence to support an empiric trial of acid suppression in
infants with symptoms associated with GER[3]. Despite
this, many physicians, seeing that parents are concerned
or upset by their infant’s continual spitting up, are now
prescribing both histamine type 2 blocking agents and
proton pump inhibitors[4].
The symptoms of GER are nonspecific, making it diffi-
cult to distinguish the fussiness, crying, and irritability
normally seen in the first months of life from colic, food
protein intolerance, or GERD [5-9].
To determine the degree of GER-associated symptoms
in a healthy population of infants, we undertook the
first prospective cohort study of nonselected infants
from birth to six-months of age using the Infant Gastro-
esophageal Reflux Questionnaire Revised (I-GERQ-R)
[10].
Methods
A consecutive sample of mother-infant pairs who deliv-
ered at Marquette General Hospital, a rural referral hos-
pital, was obtained. Exclusion criteria included follow-up
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with physicians not participating in the study (primarily
outside of Marquette, Michigan), gestational age of less
than 36 weeks, twins, and admission to the neonatal
intensive care unit.
The I-GERQ-R, a validated survey tool, was used to
determine the frequency and severity of GER symptoms
[10]. The survey was completed by the mother at the
one-month, two-month, four-month, and six-month
well child visits with the infant care provider. Each
question of the survey was evaluated for changes with
age.
Comparisons of I-GERQ-R and regurgitation fre-
quency were made. The four items of the I-GERQ-R
that addressed symptoms associated with colic (crying,
back arching)[6,7] were compared by age to the eight
items associated primarily with regurgitation.
Evaluations of changes in scores from visit to visit
were made using a t-test. I-GERQ-R scores in those
babies currently primarily breastfed were compared to
those not primarily breastfed for each postnatal visit.
Calculations were performed with SAS version 8.2 (SAS
Institute, Cary, North Carolina).
Informed consent was obtained from the mother
before entry into the study. This study protocol was
approved by the Marquette General Hospital Institu-
tional Review Board.
Results
A total of 128 mother-infant pairs of the 131 who met
the inclusion criteria were enrolled in the study from
January 23, 2006 to October 3, 2006. The mothers in
our study averaged 27.6 (standard deviation (SD) = 5.5)
years old with 1.98 (SD = 1.01) children and 2.1 (SD =
0.59) adults in the home. The babies averaged 39.6 (SD
= 1.1) weeks gestational age, birthweight of 3536 (SD =
460) grams, length of 49.9 (SD = 2.5) centimeters, and
head circumference of 34.4 (SD = 1.7) centimeters. A
review of 2098 infants born at our facility from 1999
through 2001 found that 95.19% were Caucasian, 2.43%
Native American, 1.00% mixed race, 0.86% African
American, 0.33% Hispanic, and 0.19% Asian American
[11]. No shift in the racial/ethnic characteristics of this
population has occurred in the intervening years.
The results of the I-GERQ-R surveys by age of visit
are given in Table 1 and Figure 1. The leftward shift of
the lines with age on Figure 1 indicates a leftward shift
of the distribution of I-GERQ-R scores with age consis-
tent with falling scores. The differences in individual
patients between I-GERQ-R scores between the one-
month and two-month visits was -1.52 (standard error
(SE) = 0.49, p < .05), the one-month and four-month
visits was -3.63 (SE = 0.56, p < .0001), the one-month
and six-month visits was -5.43 (SE = 0.63, p < .0001),
the two-month and four-month visits was -1.69 (SE =
0.52, p < .01), the two-month and six-month visits was
-3.16 (SE = 0.54, p < .0001), and the four-month and
six-month visits was -1.29 (SE = 0.46, p < .01). Each
visit resulted in a statistically significant decrease in the
I-GERQ-R score from the previous visit. The results of
the individual questions of the survey by each visit are
shown in Table 2.
Considering a positive score as being an I-GERQ-R
score of 16 or greater, 24 of 94 (25.5%, 95%CI = 16.7%-
34.4%) of one-month-olds were positive. At two months
this dropped to 12 of 96 (12.5%, 95%CI = 5.9%-19.1%).
At four months 8 of 100 (8.0%, 95%CI = 3.7%-13.3%)
were positive, and at six months 3 of 103 (2.9%, 95%CI
= 0%-6.2%) were positive.
The regurgitation frequency remained fairly constant
through four months of age (average regurgitations per
day: one-month 2.31 (SD = 1.90), two-month 2.19 (SD
= 1.89), four-month 2.30 (SD = 1.87)) then dropped at
six months of age (average regurgitations per day 1.46
(SD = 1.53), while the I-GERQ-R showed a steady
decline with age. When colic-associated scores and
regurgitation scores by age were compared, the colic-
associated symptoms dropped more quickly over the
first two time periods. This is confirmed by a lower per-
centage of the total I-GERQ-R score contributed by
colic-associated symptoms at two months and four
months (one-month 35.2%, two-month 32.4%, four-
month 29.4%). The rise in the percentage at six months
(32.4%) resulted primarily from the drop in regurgitation
seen between four and six months of age.
We found no correlation between maternal smoking
and colic-associated symptom scores or I-GERQ-R
scores. Likewise at each postnatal visit there was no dif-
ference in I-GERQ-R scores in those infants who were
currently primarily breastfed and those who were not
(one-month: difference = 0.56 (95%CI: -2.22, 3.35), t =
0.38, p = .71; two-month: difference = 1.28 (95%CI:
-0.72, 3.28,), t = 1.25, p = .21; four-month: difference =
-0.73 (95%CI: -2.55, 1.09), t = -0.86, p = .39; six-month:
difference = -1.04 (95%CI: -2.76, 0.67); t = -1.25, p =
.21).
Discussion
GER frequency and symptoms, as measured by the I-
GERQ-R score, decreased significantly with age. The age
pattern of the I-GERQ-R score and regurgitation fre-
quency was different with a steady decline seen in the I-
GERQ-R scores while regurgitation frequency was fairly
constant until six months of age. The effect of colic-
associated symptoms may have undue influence on the
I-GERQ-R score in the first two to four months of age.
A drop in the I-GERQ-R score of five or six is consid-
ered clinically important, while a three-point drop is
considered minimally important[10]. We found a
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clinically meaningful drop in the average from one
month of age to six months of age and a minimally
important drop from one month of age to four months
of age and from two months of age to six months of
age. However, our population was unselected, so lower
I-GERQ-R scores on average than those referred for
evaluation of GER would be expected. Consequently,
any changes in I-GERQ-R scores would be tempered by
a floor effect, which is also suggested by the narrowing
of the standard error with age.
Despite the high prevalence of GER in the first year of
life, this condition has received limited study. In a 1997
study of 948 infants, peak regurgitation (at least one epi-
sode of regurgitation a day) occurred in 51% at 0-3
months, in 67% of four-month-olds, and in 5.4% at 10
to 12 months[12].
One-year follow-up on infants who regurgitated daily
at 6 to 12 months of age found that none were still
regurgitating, but these infants were more likely to
report feeding refusal, taking more than one hour to eat
a meal, and parents dreading mealtimes[13]. In our
population at least one episode of regurgitation was
reported in the previous day in 82%, 77%, 83%, and 67%
of infants at the one-month, two-month, four-month,
and six-month visits, respectively.
In Adelaide, Australia, a peak prevalence (41%) of
“spilling” more than half of their feedings occurred
between 3 and 4 months of age. The prevalence
decreased to less than 5% by14 months of age[14]. In
Italy, 7.1% of infants had two or more episodes of regur-
gitation per day for 3 or more weeks. All had improved
at 3-month follow-up[15]. In another Italian study of
2879 infants in the first six months of life, 23.1% had
regurgitation and 20.5% had colic[16].
Several studies have focused on irritable infants. Jor-
dan et al. found that 22.8% of irritable infants had a
reflux index (RI) (percentage of total time the esopha-
geal pH is less than 4) ≥ 10%[17]. Heine et al. reported
that 4.2% of irritable infants under 3 months of age had
a RI ≥ 10% while 21.7% of infants three months and
older did[18].
Crying duration in infants peaks at six weeks of age
with the major concentration between 5 pm and 11 pm
with an average of 2.75 hours per day[6,7]. Colic, often
defined as three or more hours of crying per day for
three or more days per week for longer than two to
three weeks, peaks at the same age[19] and has an inci-
dence that ranges from 16% to 20.5%[16,19,20].
Recommended treatment for GER generally consists of
parental education, reassurance, and anticipatory gui-
dance[21]. Whether or not an infant is “excessively” irri-
table or has “troublesome” symptoms is a highly
subjective assessment. There is no evidence to indicate
that irritability in the absence of regurgitation in infants
is related to esophagitis or GER symptoms[18]. The
benefit of acid suppression in infants with GER who
have either perceived dysphagia or irritability has not
been established[3,22].
All infants have some GER,[23] the question is which
infants, if any, warrant evaluation and treatment. A
recent consensus paper concluded that for infants there
is no symptom or symptom complex that is diagnostic
of GERD or predicts the response to therapy and there
is no consistent correlation between symptoms and an
elevated RI or histiological evidence of esophagitis[3].
Environmental smoke exposure has had mixed results
with one study finding no association,[14] and two stu-
dies finding a positive association[24,25]. Our study
found no association between GER symptoms and
smoking or breastfeeding. A positive association has
been shown between GERD and private insurance,[14]
infants with lower birthweights, shorter gestation,[16]
and possibly a cow’s milk protein allergy[8,17,26]. The
most consistent symptom associated with GERD was
frequent regurgitation[18,27]. Regurgitating greater than
five time per day had a specificity of 70.9%, but a posi-
tive predictive value of 22.2%[27].
Table 1 Infant Gastroesophageal Reflux Questionnaire
Revised (I-GERQ-R) scores by visit.
Visit Mean Standard Error Median Interquartile Range
One-month
(n = 94)
11.74 5.98 10 7 to 16
Two-month
(n = 96)
9.97 4.92 9 6 to 13
Four-month
(n = 100)
8.44 4.386 8 5 to 11
Six-month
(n = 105)
6.97 4.05 7 4 to 10
Figure 1 Infant Gastroesophageal Reflux QuestionnaireRevised
(I-GERQ-R) scores by age (one-month – solid circle; two-month –
square; four-month – triangle; six-month – open circle) represented
by cumulative percentage.
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Adding to the difficulty of identifying and properly
diagnosing infants with GERD, there is only poor to fair
agreement between finding an RI ≥ 10% and a positive
esophageal biopsy[18,28]. While esophagitis may be a
significant determinant of long-term outcome,[29] the
dangers of an RI ≥ 10% in the absence of esophagitis are
unknown.
With the predominance of colic symptoms in the first
months of life and a decreased risk of GERD under
three-months of age, GERD should not be considered a
likely diagnosis until three months of age, and treatment
should be reserved for those with histological changes in
the lining of the esophagus.
This study was limited by our population: a rural
community in which the medical center and a state uni-
versity are the two biggest employers. Consequently, our
population may be more highly educated than other
rural populations in the northern Midwest. We had very
few of our participants drop out and only a few mothers
who refused to participate. We were also limited by lack
of access to pH monitoring and pediatric
esophogastroduodenoscopy.
Our study highlights the limitations of the I-GERQ-R,
which is the only available validated tool to assess GER
symptoms in infants. To date, its use has been limited
[10,30,31]. Without a clear link between symptoms and
disease, the clinical usefulness of the I-GERQ-R may be
limited. Expanded experience with the I-GERQ-R is
needed, especially at ages when colic-associated symp-
toms predominate. The values of the I-GERQ-R, or a
subset of the items in the I-GERQ-R, that are predictive
of GERD may vary with age, and this may need to be
taken into consideration when using this tool.
Conclusion
GER symptoms, as measured by the I-GERQ-R, decrease
over the first six-months of life in otherwise healthy
infants. Scores in the first months of life may be domi-
nated by colic-associated symptoms.
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Table 2 Results of individual questions of the Infant Gastroesophageal Reflux Questionnaire Revised (I-GERQ-R) by
age.
Question One-month Two-month Four-month Six-month
Regurgitation frequency* 1.12(0.09) 1.19(0.09) 1.24(0.09) 0.93(0.08)
Regurgitation volume 1.35(0.07) 1.24(0.07) 1.34(0.07) 1.08(0.08)
Regurgitation discomfort 1.05(0.11) 0.90(0.10) 0.72(0.09) 0.54(0.08)
Refuse feed when hungry 0.24(0.05) 0.21(0.05) 0.28(0.07) 0.24(0.05)
Stop feed when hungry 0.66(0.08) 0.52(0.08) 0.50(0.07) 0.45(0.07)
Cry during/after feed 1.27(0.12) 0.90(0.10) 0.57(0.07) 0.45(0.06)
Cry greater than usual 1.21(0.11) 0.90(0.09) 0.87(0.09) 0.85(0.09)
Cry duration* 0.93(0.09) 0.77(0.08) 0.60(0.07) 0.55(0.06)
Hiccups 2.68(0.08) 2.33(0.10) 1.57(0.10) 1.25(0.08)
Arching 1.13(0.10) 0.86(0.10) 0.72(0.08) 0.57(0.08)
Apnea (awake/struggle)† 0.12(0.05) 0.14(0.05) 0(0) 0.02(0.02)
Turned blue† 0(0) 0.02(0.02) 0(0) 0(0)
Overall severity§ 1.37(0.11) 1.23(0.11) 1.18(0.10) 0.88(0.09)
Scores for each question ranged from 0 to 4 except where indicated.
* Score for question ranged from 0 to 3.
† Score for question ranged from 0 to 2.
§Question asked as part of I-GERQ-R, but score not incorporated into I-GERQ-R score.
Mean score (Standard deviation)
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